Pfizer’s boss thinks covid-19 is reshaping Big Pharma for the better
The industry is becoming nimbler and more innovative
“THE IMPOSSIBLE can many times become possible,” reflects Albert Bourla, boss of Pfizer. He is talking about the giant American drugmaker’s speedy development (with BioNTech of Germany) of a vaccine against covid-19. The sentiment also applies to the turnaround in the fortunes of the pharmaceutical industry.
This article appeared in the Business section of the print edition under the headline “Reformulated”
Business April 10th 2021
From the April 10th 2021 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Business
A $500bn investment plan says a lot about Trump’s AI priorities
It’s build, baby, build
Donald Trump’s America will not become a tech oligarchy
Reasons not to panic about the tech-industrial complex
OpenAI’s latest model will change the economics of software
The more reasoning it does, the more computer power it uses
TikTok’s time is up. Can Donald Trump save it?
The imperilled app hopes for help from an old foe
The UFC, Dana White and the rise of bloodsport entertainment
There is more to the mixed-martial-arts impresario than his friendship with Donald Trump
Will Elon Musk scrap his plan to invest in a gigafactory in Mexico?
Donald Trump’s return to the White House may have changed Tesla’s plans